Advanced Micro Devices Valuation
Is AMD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMD * (MX$2550.77) is trading above our estimate of fair value (MX$1486.68)
Significantly Below Fair Value: AMD * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMD *?
Other financial metrics that can be useful for relative valuation.
What is AMD *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$243.42b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 10.5x |
Enterprise Value/EBITDA | 62.6x |
PEG Ratio | 5.8x |
Price to Sales Ratio vs Peers
How does AMD *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 8.2x | ||
QCOM QUALCOMM | 5.5x | 8.4% | US$201.0b |
ADI Analog Devices | 8.6x | 4.2% | US$97.4b |
TXN Texas Instruments | 9.7x | 7.7% | US$160.1b |
2330 Taiwan Semiconductor Manufacturing | 9x | 15.4% | NT$20.2t |
AMD * Advanced Micro Devices | 10.7x | 16.7% | Mex$243.4b |
Price-To-Sales vs Peers: AMD * is expensive based on its Price-To-Sales Ratio (10.7x) compared to the peer average (8.2x).
Price to Earnings Ratio vs Industry
How does AMD *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Sales vs Industry: AMD * is expensive based on its Price-To-Sales Ratio (10.7x) compared to the Global Semiconductor industry average (3.3x).
Price to Sales Ratio vs Fair Ratio
What is AMD *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 10.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AMD *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,550.77 | Mex$3,194.02 +25.2% | 13.7% | Mex$4,248.53 | Mex$2,124.26 | n/a | 42 |
Apr ’25 | Mex$3,050.00 | Mex$3,297.91 +8.1% | 15.4% | Mex$4,540.97 | Mex$2,270.48 | n/a | 43 |
Mar ’25 | Mex$3,440.43 | Mex$3,294.16 -4.3% | 14.0% | Mex$4,621.86 | Mex$2,310.93 | n/a | 43 |
Feb ’25 | Mex$2,918.69 | Mex$3,181.64 +9.0% | 15.7% | Mex$4,646.35 | Mex$2,151.09 | n/a | 43 |
Jan ’25 | Mex$2,500.15 | Mex$2,322.77 -7.1% | 14.7% | Mex$3,406.46 | Mex$1,669.17 | n/a | 43 |
Dec ’24 | Mex$2,082.00 | Mex$2,296.13 +10.3% | 15.1% | Mex$3,472.72 | Mex$1,701.63 | n/a | 42 |
Nov ’24 | Mex$1,924.00 | Mex$2,347.15 +22.0% | 15.4% | Mex$3,562.46 | Mex$1,745.61 | n/a | 42 |
Oct ’24 | Mex$1,797.31 | Mex$2,426.96 +35.0% | 13.5% | Mex$3,447.04 | Mex$1,637.34 | n/a | 41 |
Sep ’24 | Mex$1,870.20 | Mex$2,393.58 +28.0% | 14.1% | Mex$3,419.52 | Mex$1,624.27 | n/a | 41 |
Aug ’24 | Mex$1,982.30 | Mex$2,248.97 +13.5% | 18.4% | Mex$3,348.88 | Mex$1,406.53 | n/a | 41 |
Jul ’24 | Mex$1,952.78 | Mex$2,239.53 +14.7% | 21.0% | Mex$3,411.26 | Mex$1,364.50 | n/a | 39 |
Jun ’24 | Mex$2,103.19 | Mex$1,894.38 -9.9% | 23.6% | Mex$3,537.68 | Mex$1,362.01 | n/a | 39 |
May ’24 | Mex$1,605.89 | Mex$1,781.57 +10.9% | 22.5% | Mex$3,585.72 | Mex$1,219.14 | Mex$2,730.51 | 37 |
Apr ’24 | Mex$1,760.00 | Mex$1,750.55 -0.5% | 23.8% | Mex$3,618.52 | Mex$1,212.20 | Mex$3,050.00 | 38 |
Mar ’24 | Mex$1,424.00 | Mex$1,724.87 +21.1% | 23.8% | Mex$3,703.10 | Mex$1,240.54 | Mex$3,440.43 | 36 |
Feb ’24 | Mex$1,578.83 | Mex$1,701.75 +7.8% | 24.5% | Mex$3,724.20 | Mex$1,210.37 | Mex$2,918.69 | 36 |
Jan ’24 | Mex$1,260.14 | Mex$1,766.88 +40.2% | 26.6% | Mex$3,951.32 | Mex$1,185.40 | Mex$2,500.15 | 37 |
Dec ’23 | Mex$1,485.97 | Mex$1,748.37 +17.7% | 26.4% | Mex$3,909.28 | Mex$1,172.78 | Mex$2,082.00 | 38 |
Nov ’23 | Mex$1,177.98 | Mex$1,833.10 +55.6% | 26.8% | Mex$3,962.88 | Mex$1,188.86 | Mex$1,924.00 | 37 |
Oct ’23 | Mex$1,286.52 | Mex$2,410.70 +87.4% | 17.9% | Mex$4,034.64 | Mex$1,613.86 | Mex$1,797.31 | 36 |
Sep ’23 | Mex$1,648.78 | Mex$2,446.54 +48.4% | 17.3% | Mex$4,037.20 | Mex$1,614.88 | Mex$1,870.20 | 35 |
Aug ’23 | Mex$1,973.45 | Mex$2,498.20 +26.6% | 20.9% | Mex$4,074.78 | Mex$1,283.56 | Mex$1,982.30 | 34 |
Jul ’23 | Mex$1,490.41 | Mex$2,624.42 +76.1% | 20.0% | Mex$4,049.14 | Mex$1,275.48 | Mex$1,952.78 | 35 |
Jun ’23 | Mex$2,009.76 | Mex$2,601.70 +29.5% | 19.0% | Mex$3,920.14 | Mex$1,568.06 | Mex$2,103.19 | 34 |
May ’23 | Mex$1,749.06 | Mex$2,905.95 +66.1% | 16.1% | Mex$4,050.52 | Mex$2,025.26 | Mex$1,605.89 | 34 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.